Company Profile
AQTIS Medical™ focuses on setting new standards within the current trends in the bioresorbable medical aesthetics industry and bases its competitive strategy on its innovative cutting-edge technology and superior product quality, performance and service.
Our distinctive competence is the modification and functionalization of bioresorbable polymers and gels in relation to desired device performance characteristics. Our unique proprietary technology platform is the basis of our bioresorbable medical polymer and gel formulations, including our Ellansé™ family.
Our growth strategy is levered by the Ellansé™ dermal filler family, supported by the continuous strengthening of our sales and marketing organization. We are broadening our portfolio with additional, regulatory approved, complementary products within the medical aesthetics and other therapeutic areas. This is complemented by our state-of-the-art manufacturing and operational facilities.
We aim to become the first choice for medical aesthetic bioresorbable solutions.
Our distinctive competence is the modification and functionalization of bioresorbable polymers and gels in relation to desired device performance characteristics. Our unique proprietary technology platform is the basis of our bioresorbable medical polymer and gel formulations, including our Ellansé™ family.
Our growth strategy is levered by the Ellansé™ dermal filler family, supported by the continuous strengthening of our sales and marketing organization. We are broadening our portfolio with additional, regulatory approved, complementary products within the medical aesthetics and other therapeutic areas. This is complemented by our state-of-the-art manufacturing and operational facilities.
We aim to become the first choice for medical aesthetic bioresorbable solutions.